Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage
Authors
- Kazuki Maesaka
- Takahiro Kodama (ORCID: https://orcid.org/0000-0002-6250-1324)
- Yoshinobu Saito (ORCID: https://orcid.org/0000-0002-0624-0449)
- Shinji Kuriki (ORCID: https://orcid.org/0009-0002-4554-7926)
- Kazuhiro Murai (ORCID: https://orcid.org/0000-0001-8634-2922)
- Yuki Tahata (ORCID: https://orcid.org/0000-0002-9116-7054)
- Satoshi Minami (ORCID: https://orcid.org/0000-0001-5043-3435)
- Akiyoshi Shimoda
- Hayato Hikita (ORCID: https://orcid.org/0000-0003-2488-7315)
- Emi Sometani (ORCID: https://orcid.org/0009-0003-5920-1472)
- Kumiko Shirai
- Satoshi Shigeno
- Tetsuo Takehara
- Takeshi Takahashi
- Takayuki Miyake
- Jihyun Sung
- Yuichiro Higuchi
Institutions
- Osaka Gakuin University (JP)
- Central Institute for Experimental Animals (JP)
- The University of Osaka (JP)